{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:27:12Z","timestamp":1778783232811,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10637-021-01196-1","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T10:19:46Z","timestamp":1635243586000},"page":"245-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells"],"prefix":"10.1007","volume":"40","author":[{"given":"Chie","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3998-6711","authenticated-orcid":false,"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"1196_CR1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","volume":"3","author":"M Iwanaga","year":"2012","unstructured":"Iwanaga M, Watanabe T, Yamaguchi K (2012) Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol 3:322","journal-title":"Front Microbiol"},{"key":"1196_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-4939-6872-5_15","volume":"1582","author":"R Nasr","year":"2017","unstructured":"Nasr R, Mar\u00e7ais A, Hermine O, Bazarbachi A (2017) Overview of targeted therapies for adult T-cell leukemia\/lymphoma. Methods Mol Biol 1582:197\u2013216","journal-title":"Methods Mol Biol"},{"key":"1196_CR3","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","volume":"15","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka K, Tamura K (2014) Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol 15:e517\u2013e526","journal-title":"Lancet Oncol"},{"key":"1196_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-4690-2-27","volume":"2","author":"M Matsuoka","year":"2005","unstructured":"Matsuoka M (2005) Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2:27","journal-title":"Retrovirology"},{"key":"1196_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fmicb.2012.00334","volume":"3","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi M, Watanabe T (2012) Molecular hallmarks of adult T cell leukemia. Front Microbiol 3:334","journal-title":"Front Microbiol"},{"key":"1196_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pathogens9070543","volume":"9","author":"S Mohanty","year":"2020","unstructured":"Mohanty S, Harhaj EW (2020) Mechanisms of oncogenesis by HTLV-1 Tax. Pathogens 9:543","journal-title":"Pathogens"},{"key":"1196_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1158\/1078-0432.CCR-16-2071","volume":"23","author":"MG Cardenas","year":"2017","unstructured":"Cardenas MG, Oswald E, Yu W, Xue F, MacKerell AD Jr, Melnick AM (2017) The expanding role of the BCL6 oncoprotein as a cancer therapeutic target. Clin Cancer Res 23:885\u2013893","journal-title":"Clin Cancer Res"},{"key":"1196_CR8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.7150\/jca.25732","volume":"10","author":"S Li","year":"2019","unstructured":"Li S, Wang Z, Lin L, Wu Z, Yu Q, Gao F, Zhang J, Xu Y (2019) BCL6 rearrangement indicates poor prognosis in diffuse large B-cell lymphoma patients: a meta-analysis of cohort studies. J Cancer 10:530\u2013538","journal-title":"J Cancer"},{"key":"1196_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/294770a0","volume":"294","author":"I Miyoshi","year":"1981","unstructured":"Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y (1981) Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770\u2013771","journal-title":"Nature"},{"key":"1196_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1126\/science.6980467","volume":"217","author":"N Yamamoto","year":"1982","unstructured":"Yamamoto N, Okada M, Koyanagi Y, Kannagi M, Hinuma Y (1982) Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science 217:737\u2013739","journal-title":"Science"},{"key":"1196_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1182\/blood.V64.2.482.482","volume":"64","author":"HP Koeffler","year":"1984","unstructured":"Koeffler HP, Chen IS, Golde DW (1984) Characterization of a novel HTLV-infected cell line. Blood 64:482\u2013490","journal-title":"Blood"},{"key":"1196_CR12","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415\u20137419","journal-title":"Proc Natl Acad Sci USA"},{"key":"1196_CR13","first-page":"155","volume":"71","author":"I Miyoshi","year":"1980","unstructured":"Miyoshi I, Kubonishi I, Sumida M, Hiraki S, Tsubota T, Kimura I, Miyamoto K, Sato J (1980) A novel T-cell line derived from adult T-cell leukemia. Gan 71:155\u2013156","journal-title":"Gan"},{"key":"1196_CR14","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/nar\/17.4.1589","volume":"17","author":"K Ohtani","year":"1989","unstructured":"Ohtani K, Nakamura M, Saito S, Nagata K, Sugamura K, Hinuma Y (1989) Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. Nucleic Acids Res 17:1589\u20131604","journal-title":"Nucleic Acids Res"},{"key":"1196_CR15","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.4049\/jimmunol.157.9.3980","volume":"157","author":"C Zhang","year":"1996","unstructured":"Zhang C, Ao Z, Seth A, Schlossman SF (1996) A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol 157:3980\u20133987","journal-title":"J Immunol"},{"key":"1196_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1349-7006.1990.tb02554.x","volume":"81","author":"Y Tanaka","year":"1990","unstructured":"Tanaka Y, Yoshida A, Takayama Y, Tsujimoto H, Tsujimoto A, Hayami M, Tozawa H (1990) Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses. Jpn J Cancer Res 81:225\u2013231","journal-title":"Jpn J Cancer Res"},{"key":"1196_CR17","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3892\/ijo.2015.2848","volume":"46","author":"N Mori","year":"2015","unstructured":"Mori N, Ishikawa C, Senba M (2015) Activation of PKC-\u03b4 in HTLV-1-infected T cells. Int J Oncol 46:1609\u20131618","journal-title":"Int J Oncol"},{"key":"1196_CR18","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, Ishii R, Muto S, Kotani S, Watatani Y, Takeda J, Sanada M, Tanaka H, Suzuki H, Sato Y, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Iwanaga M, Ma G, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Ogasawara H, Sato T, Sasai K, Muramoto K, Penova M, Kawaguchi T, Nakamura H, Hama N, Shide K, Kubuki Y, Hidaka T, Kameda T, Nakamaki T, Ishiyama K, Miyawaki S, Yoon SS, Tobinai K, Miyazaki Y, Takaori-Kondo A, Matsuda F, Takeuchi K, Nureki O, Aburatani H, Watanabe T, Shibata T, Matsuoka M, Miyano S, Shimoda K, Ogawa S (2015) Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet 47:1304\u20131315","journal-title":"Nat Genet"},{"key":"1196_CR19","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/intimm\/dxl041","volume":"18","author":"E Arguni","year":"2006","unstructured":"Arguni E, Arima M, Tsuruoka N, Sakamoto A, Hatano M, Tokuhisa T (2006) JunD\/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells. Int Immunol 18:1079\u20131089","journal-title":"Int Immunol"},{"key":"1196_CR20","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3389\/fmicb.2017.02686","volume":"8","author":"H Gazon","year":"2018","unstructured":"Gazon H, Barbeau B, Mesnard JM, Peloponese JM Jr (2018) Hijacking of the AP-1 signaling pathway during development of ATL. Front Microbiol 8:2686","journal-title":"Front Microbiol"},{"key":"1196_CR21","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1002\/j.1460-2075.1986.tb04583.x","volume":"5","author":"J Inoue","year":"1986","unstructured":"Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M (1986) Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J 5:2883\u20132888","journal-title":"EMBO J"},{"key":"1196_CR22","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1172\/JCI85795","volume":"126","author":"MG Cardenas","year":"2016","unstructured":"Cardenas MG, Yu W, Beguelin W, Teater MR, Geng H, Goldstein RL, Oswald E, Hatzi K, Yang SN, Cohen J, Shaknovich R, Vanommeslaeghe K, Cheng H, Liang D, Cho HJ, Abbott J, Tam W, Du W, Leonard JP, Elemento O, Cerchietti L, Cierpicki T, Xue F, MacKerell AD Jr, Melnick AM (2016) Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma. J Clin Invest 126:3351\u20133362","journal-title":"J Clin Invest"},{"key":"1196_CR23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","volume":"1849","author":"G Bretones","year":"2015","unstructured":"Bretones G, Delgado MD, Le\u00f3n J (2015) Myc and cell cycle control. Biochim Biophys Acta 1849:506\u2013516","journal-title":"Biochim Biophys Acta"},{"key":"1196_CR24","doi-asserted-by":"publisher","first-page":"59950","DOI":"10.18632\/oncotarget.19048","volume":"8","author":"H-C Zheng","year":"2017","unstructured":"Zheng H-C (2017) The molecular mechanisms of chemoresistance in cancers. Oncotarget 8:59950\u201359964","journal-title":"Oncotarget"},{"key":"1196_CR25","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2741\/3319","volume":"14","author":"N Mori","year":"2009","unstructured":"Mori N (2009) Cell signaling modifiers for molecular targeted therapy in ATLL. Front Biosci 14:1479\u20131489","journal-title":"Front Biosci"},{"key":"1196_CR26","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.7314\/APJCP.2015.16.6.2129","volume":"16","author":"S Goldar","year":"2015","unstructured":"Goldar S, Khaniani MS, Derakhshan SM, Baradaran B (2015) Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev 16:2129\u20132144","journal-title":"Asian Pac J Cancer Prev"},{"key":"1196_CR27","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1038\/onc.2008.312","volume":"27","author":"B Hoffman","year":"2008","unstructured":"Hoffman B, Liebermann DA (2008) Apoptotic signaling by c-MYC. Oncogene 27:6462\u20136472","journal-title":"Oncogene"},{"key":"1196_CR28","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL (1999) Activators and target genes of Rel\/NF-\u03baB transcription factors. Oncogene 18:6853\u20136866","journal-title":"Oncogene"},{"key":"1196_CR29","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/sj.onc.1204304","volume":"20","author":"R Iwanaga","year":"2001","unstructured":"Iwanaga R, Ohtani K, Hayashi T, Nakamura M (2001) Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene 20:2055\u20132067","journal-title":"Oncogene"},{"key":"1196_CR30","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1158\/1940-6207.CAPR-10-0037","volume":"3","author":"S Reuter","year":"2010","unstructured":"Reuter S, Prasad S, Phromnoi K, Ravindran J, Sung B, Yadav VR, Kannappan R, Chaturvedi MM, Aggarwal BB (2010) Thiocolchicoside exhibits anticancer effects through downregulation of NF-\u03baB pathway and its regulated gene products linked to inflammation and cancer. Cancer Prev Res 3:1462\u20131472","journal-title":"Cancer Prev Res"},{"key":"1196_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","volume":"30","author":"P Viatour","year":"2005","unstructured":"Viatour P, Merville M-P, Bours V, Chariot A (2005) Phosphorylation of NF-\u03baB and I\u03baB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43\u201352","journal-title":"Trends Biochem Sci"},{"key":"1196_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/sj.onc.1203383","volume":"19","author":"J Shao","year":"2000","unstructured":"Shao J, Fujiwara T, Kadowaki Y, Fukazawa T, Waku T, Itoshima T, Yamatsuji T, Nishizaki M, Roth JA, Tanaka N (2000) Overexpression of the wild-type p53 gene inhibits NF-\u03baB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells. Oncogene 19:726\u2013736","journal-title":"Oncogene"},{"key":"1196_CR33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/ncb1724","volume":"10","author":"K Kawauchi","year":"2008","unstructured":"Kawauchi K, Araki K, Tobiume K, Tanaka N (2008) p53 regulates glucose metabolism through an IKK-NF-\u03baB pathway and inhibits cell transformation. Nat Cell Biol 10:611\u2013618","journal-title":"Nat Cell Biol"},{"key":"1196_CR34","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1126\/science.1193494","volume":"330","author":"AJ Levine","year":"2010","unstructured":"Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330:1340\u20131344","journal-title":"Science"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-021-01196-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-021-01196-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-021-01196-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:40:52Z","timestamp":1678509652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-021-01196-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1007\/s10637-021-01196-1","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors consent to the publication of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"No potential competing interest is reported by the authors. No potential conflict of interest is reported by the authors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}